These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9626797)

  • 1. Advanced carcinoma of the pancreas: phase II study of combined chemotherapy, beta-interferon, and retinoids.
    Recchia F; Sica G; Casucci D; Rea S; Gulino A; Frati L
    Am J Clin Oncol; 1998 Jun; 21(3):275-8. PubMed ID: 9626797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined chemotherapy and differentiation therapy in the treatment of advanced non-small-cell lung cancer.
    Recchia F; Sica G; De Filippis S; Rea S; Frati L
    Anticancer Res; 1997; 17(5B):3761-5. PubMed ID: 9427776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas.
    Choi CW; Choi IK; Seo JH; Kim BS; Kim JS; Kim CD; Um SH; Kim JS; Kim YH
    Am J Clin Oncol; 2000 Aug; 23(4):425-8. PubMed ID: 10955877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of advanced pancreatic cancer with epirubicin, 5-fluorouracil and 1-leucovorin: a phase II study.
    Raderer M; Kornek GV; Hejna MH; Weinlaender G; Vorbeck F; Fiebiger WC; Scheithauer W
    Ann Oncol; 1997 Aug; 8(8):797-9. PubMed ID: 9332689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of fluorouracil by methotrexate, leucovorin, and cisplatin (M-FLP) in the treatment of advanced pancreatic cancer: a phase II study of the Italian Oncology Group for Clinical Research (GOIRC).
    Di Costanzo F; Canaletti R; Sdrobolini A; Olmeo N; Luppi G; Pucci F; Cavicchi F; Gasperoni S; Rodinò C; Zironi S; Angiona S; Contu A
    Am J Clin Oncol; 2000 Jun; 23(3):314-8. PubMed ID: 10857901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Fluorouracil, epirubicin, and mitomycin C versus 5-fluorouracil, epirubicin, mitomycin C, and leucovorin in advanced gastric carcinoma. A randomized trial.
    Tsavaris NB; Tentas K; Kosmidis P; Mylonakis N; Sakelaropoulos N; Kosmas C; Lisaios B; Soumilas A; Mandrekois D; Tsetis A; Klonaris C
    Am J Clin Oncol; 1996 Oct; 19(5):517-21. PubMed ID: 8823483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of infusional fluorouracil, leucovorin, mitomycin, and dipyridamole in locally advanced unresectable pancreatic adenocarcinoma: SWOG S9700.
    Isacoff WH; Bendetti JK; Barstis JJ; Jazieh AR; Macdonald JS; Philip PA
    J Clin Oncol; 2007 May; 25(13):1665-9. PubMed ID: 17470859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of advanced pancreatic adenocarcinoma with 5-FU, leucovorin, interferon-alpha-2b, and cisplatin.
    Sporn JR; Buzaid AC; Slater D; Cohen N; Greenberg BR
    Am J Clin Oncol; 1997 Feb; 20(1):81-3. PubMed ID: 9020295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized study of bolus fluorouracil plus folinic acid versus 21-day fluorouracil infusion alone or in association with cyclophosphamide and mitomycin C in advanced colorectal carcinoma.
    Caudry M; Bonnel C; Floquet A; Marsault C; Quétin P; Pujol J; Maton O; Dujols JP; Caudry Y; Skawinski P
    Am J Clin Oncol; 1995 Apr; 18(2):118-25. PubMed ID: 7900703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of prolonged continuous infusion of 5-fluorouracil and interferon-alpha in patients with advanced pancreatic cancer. Eastern Cooperative Oncology Group Protocol 3292.
    Sparano JA; Lipsitz S; Wadler S; Hansen R; Bushunow PW; Kirkwood J; Flynn PJ; Dutcher JP; Benson AB
    Am J Clin Oncol; 1996 Dec; 19(6):546-51. PubMed ID: 8931668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus g-csf in advanced gastric cancer: a multicentric phase II study.
    Felici A; Carlini P; Ruggeri EM; Gamucci T; Pollera CF; De Marco S; Fariello AM; Moscetti L; Gelibter A; Adami E; Sperduti I; Cognetti F
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):59-64. PubMed ID: 16001173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG study.
    Wagener DJ; Hoogenraad WJ; Rougier P; Lusinchi A; Taal BG; Veenhof CH; de Graeff A; Conroy T; Curran D; Sahmoud T; Wils J
    Eur J Cancer; 1996 Jul; 32A(8):1310-3. PubMed ID: 8869091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Cancer Treatment Group Trial.
    Burch PA; Ghosh C; Schroeder G; Allmer C; Woodhouse CL; Goldberg RM; Addo F; Bernath AM; Tschetter LK; Windschitl HE; Cobau CD
    Am J Clin Oncol; 2000 Oct; 23(5):534-7. PubMed ID: 11039519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of single-agent epirubicin and 5-fluorouracil/epirubicin/mitomycin in patients with advanced adenocarcinoma of the pancreas.
    Topham C; Glees J; Coombes RC
    Oncology; 1993 Apr; 50 Suppl 1():78-80. PubMed ID: 8483561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II trial of etoposide, leucovorin, 5-FU, and interferon alpha 2b (ELFI) + G-CSF for patients with pancreatic adenocarcinoma: a Southwest Oncology Group study (SWOG 9413).
    Macdonald JS; Jacobson JL; Modiano M; Moore DF; Gandara DR; Schroder LE; Chapman RA
    Invest New Drugs; 2000 Aug; 18(3):269-73. PubMed ID: 10958597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
    J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined epirubicin, 5-fluorouracil and folinic acid vs no treatment for patients with advanced pancreatic cancer: a prospective comparative study.
    Tsavaris N; Tentas K; Tzivras M; Kosmas C; Kalachanis N; Katsikas M; Dimitrakopoulos A; Papastratis G; Macheras A; Karatzas G; Sechas M
    J Chemother; 1998 Aug; 10(4):331-7. PubMed ID: 9720474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose 5-fluorouracil / folinic acid in combination with three-weekly mitomycin C in the treatment of advanced gastric cancer. A phase II study.
    Hofheinz RD; Hartung G; Samel S; Hochhaus A; Pichlmeier U; Post S; Hehlmann R; Queisser W
    Onkologie; 2002 Jun; 25(3):255-60. PubMed ID: 12119460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
    Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
    Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.